Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    Trans-Alaskan Pipeline To Be Made-in-Korea Steel — CPA Raises Concern and Alarm

    Trans-Alaskan Pipeline To Be Made-in-Korea Steel — CPA Raises Concern and Alarm

    December 10, 2025

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    Trans-Alaskan Pipeline To Be Made-in-Korea Steel — CPA Raises Concern and Alarm

    China’s Beating America to the Moon. Witnesses Tell House Space Committee Needs More Government Action.

    Democrats Keep Anti-Tariff Bias In House Small Business Hearing. Steel and Aluminum Tariffs Criticized by Importers

    The Affordability Crisis Has Nothing To Do With Tariffs

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

China is flooding the global market with solar panels. It’s part of an aggressive strategy by Beijing to dominate the world’s solar industry.

Ohio’s Solar Manufacturers Deserve a Level Playing Field

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Manufacturing, Newsroom, Trade and TariffsBy Michael StumoJune 24, 2024

China is flooding the global market with solar panels. It’s part of an aggressive strategy by Beijing to dominate the world’s solar industry.

How to address America’s historic drug shortage crisis

How to Address America’s Historic Drug Shortage Crisis

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Manufacturing, Newsroom, op-ed, Supply ChainBy CPA NewsroomJune 20, 2024

The United States is facing an unprecedented drug shortage, with a record 323 active drug shortages at the start of 2024 — the highest number since 2001.

Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls

Rx Import Alert: CVS Branded Generic Drugs Singled Out In Bloomberg Report For Most Recalls

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Manufacturing, Newsroom, Supply ChainBy Kenneth RapozaJune 13, 2024

The foreign labs in China and India that make the branded drugs for CVS pharmacies nationwide are coming under increased scrutiny for unsafe manufacturing practices.

FDA Official Laments To Congress That Drug Recall Decisions Rely On Foreign Labs

FDA Official Laments To Congress That Drug Recall Decisions Rely On Foreign Labs

Archive, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Industrial Policy, Manufacturing, NewsroomBy Kenneth RapozaMay 24, 2024

When drugs are pulled from pharmacy shelves, it’s somewhat of a well-kept secret that it is the pharmaceutical company that voluntarily warns buyers of the potential harm from the defect.

Indian Pharmaceutical Company Zydus Lifesciences Fails 10 FDA Requirements

Indian Pharmaceutical Company Zydus Lifesciences Fails 10 FDA Requirements

Archive, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Manufacturing, NewsroomBy Kenneth RapozaMay 2, 2024

Generic drug exporter Zydus Lifesciences received poor marks again in April following a Food and Drug Administration inspection of its lab in Vadodara, a city in Gujarat state on India’s western coast.

Veterans Hospitals Ban Use of China-Made Syringes Due to Safety Issues

Veterans Hospitals Ban Use of China-Made Syringes Due to Safety Issues

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Healthcare, Newsroom, Supply ChainBy Kenneth RapozaMay 1, 2024

The Veterans Health Administration (VHA) banned the use of plastic syringes made in China on April 23 due to safety concerns, ahead of a warning letter dated April 24 to Ohio-based importer Cardinal Health by the Food and Drug Administration.

Solar Panels

CPA Strongly Supports New Solar Trade Case Filed by Major U.S. Solar Manufacturers

Archive, China, CPA News, Featured Home Page, Guest Opinion & Press Releases, Manufacturing, Newsroom, Press Release, Renewable EnergyBy CPA NewsroomApril 24, 2024

CPA strongly supported a previous AD/CVD case filed by Auxin Solar where the Commerce Department determined that Chinese companies operating in Malaysia, Thailand, Vietnam, and Cambodia are illegally circumventing.

Drug Shortages

America’s Life-Threatening Drug Shortages Reach Record Highs

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Guest Opinion & Press Releases, Healthcare, Manufacturing, Newsroom, op-ed, Op-Ed & PR Featured, Supply ChainBy CPA NewsroomApril 3, 2024

Despite spending over $600 billion on prescription drugs, the number of drugs in shortage rose to a near-record total of 301 active medication shortages at the end of 2023.

Surge in Pharmaceutical Imports Threatens U.S. National Security as India/China Dominance Grows

Archive, Featured Home Page, Featured Research, Research, Research Hub ArticlesBy Jeff FerryMarch 21, 2024

KEY POINTS U.S. pharmaceutical imports have risen sharply in the last decade, with imports from China and India skyrocketing. India and China are increasingly the

Aurobindo

America’s Largest Generic Drug Supplier Aurobindo is in Deep with China’s Military

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Guest Opinion & Press Releases, Healthcare, Manufacturing, Newsroom, op-ed, Op-Ed & PR Featured, Supply ChainBy Michael StumoMarch 6, 2024

America’s largest generic drug supplier, Aurobindo, is riddled with safety and quality issues, including ties to overseas suppliers with links to China’s military.

←123456…
7891011121314
15→
  • ABOUT
  • NEWSROOM
  • MEMBERSHIP
  • CONTACT
Facebook-f Youtube Linkedin

© 2025 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Twitter
 Facebook
 LinkedIn
 Copy

Share on Mastodon